Top Page
Oneview Healthcare Chess Depository Interests repr 1
(OTC:ONE)
Oneview Healthcare Chess Depository Interests repr 1 (ONE) vs. S&P 500 (SPY)
Oneview Healthcare Chess Depository Interests repr 1 Business Overview & Revenue Model
Oneview Healthcare Chess Depository Interests repr 1 Financial Statement Overview
| Breakdown | ||||
| Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|
| Income Statement | Total Revenue | |||
| 9.89M | 9.40M | 8.92M | 9.73M | 7.10M | Gross Profit |
| 6.67M | 6.16M | 5.35M | 5.31M | 4.72M | EBIT |
| -11.36M | -8.37M | -10.76M | -8.01M | -8.23M | EBITDA |
| -11.26M | -7.88M | -15.38M | -7.42M | -8.18M | Net Income Common Stockholders |
| -10.84M | -8.93M | -10.87M | -8.19M | -9.45M |
| Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
| 13.83M | 11.55M | 6.41M | 15.18M | 6.80M | Total Assets |
| 25.96M | 21.92M | 12.75M | 21.09M | 14.25M | Total Debt |
| 1.15M | 935.32K | 543.01K | 1.20M | 1.51M | Net Debt |
| -12.68M | -10.61M | -5.87M | -13.97M | -5.29M | Total Liabilities |
| 12.71M | 12.78M | 10.50M | 11.19M | 10.18M | Stockholders Equity |
| 13.25M | 9.14M | 2.26M | 9.90M | 4.07M |
| Cash Flow | Free Cash Flow | |||
| -10.52M | -7.79M | -10.24M | -4.09M | -7.94M | Operating Cash Flow |
| -10.47M | -7.26M | -10.20M | -4.03M | -7.69M | Investing Cash Flow |
| -459.78K | -521.38K | -44.52K | -65.26K | -249.35K | Financing Cash Flow |
| 13.14M | 13.04M | -100.11K | 12.22M | 4.95M |
Oneview Healthcare Chess Depository Interests repr 1 Technical Analysis
Oneview Healthcare Chess Depository Interests repr 1 Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
69 Neutral | $9.91B | 193.11 | 14.52% | ― | 55.85% | 893.42% | |
66 Neutral | AU$34.90M | 19.07 | 87.09% | 9.79% | 1.86% | 16.10% | |
64 Neutral | AU$17.93M | 140.00 | -3.11% | ― | 89.13% | 69.57% | |
64 Neutral | AU$57.38M | 110.00 | -8.34% | ― | -5.27% | 50.29% | |
52 Neutral | $5.15B | 3.56 | -42.52% | 2.83% | 14.56% | -0.53% | |
49 Neutral | AU$216.00M | ― | ― | 5.87% | 4.06% | ||
37 Underperform | $171.74M | ― | -99.05% | ― | ― | -34.09% |
Oneview Healthcare Chess Depository Interests repr 1 Corporate Events
Oneview Healthcare PLC reported a net cash outflow of €1.6 million for Q1 2025, with strong customer receipts inflows of €4.2 million, reflecting improved financial performance compared to the previous year. The company is actively expanding its market presence through strategic partnerships and product innovations, including the launch of its AI-driven Virtual Patient Assistant, Ovie. The company is also progressing with significant deployment projects and is in contract negotiations with major healthcare systems, positioning itself for continued growth despite potential tariff impacts.
Oneview Healthcare PLC has announced a change in the director’s interest notice, specifically involving Barbara Nelson. The change includes the acquisition of 208,333 Chess Depository Interests (CDIs) upon the vesting of Restricted Share Units (RSUs) and the sale of 102,083 CDIs to settle mandatory Irish payroll income taxes. This adjustment results in a net increase in Nelson’s holdings, reflecting a strategic move to manage tax obligations while maintaining a significant stake in the company.
Oneview Healthcare PLC has announced a change in the director’s interest, with Darragh Lyons acquiring 150,000 Chess Depository Interests (CDIs) as a result of the vesting of Restricted Share Units (RSUs). This change reflects an increase in the director’s holdings, indicating confidence in the company’s future performance and potentially impacting stakeholder perceptions positively.
Oneview Healthcare PLC has announced a new application for the quotation of securities on the Australian Securities Exchange (ASX). The company will be quoting 3,778,728 CHESS Depositary Interests, which were previously issued under an employee incentive scheme. This move is likely to impact the company’s market presence by increasing its visibility and potentially attracting more investors.
Oneview Healthcare Plc has released its Corporate Governance Statement, detailing its adherence to the ASX Corporate Governance Council’s principles and recommendations. The statement, which is available on the company’s website, outlines the company’s governance practices, including board responsibilities, director appointments, and executive agreements. This release underscores Oneview Healthcare’s commitment to transparency and accountability, which may positively impact its reputation and stakeholder trust.
Oneview Healthcare PLC has reaffirmed its commitment to high ethical standards and corporate governance by adhering to the ASX Corporate Governance Council’s principles. The company has outlined its governance framework, emphasizing the roles and responsibilities of its Board and management, aiming to protect and enhance shareholder value. This governance statement reflects Oneview’s strategic direction and operational oversight, which are crucial for maintaining stakeholder trust and ensuring long-term success.
Oneview Healthcare PLC has announced a change in the director’s interest, specifically involving James Fitter. The change involves the lapse of 6,400,000 Restricted Share Units over CDIs due to unmet vesting conditions, reducing the total unvested units held by the director. This adjustment reflects the company’s adherence to performance-based vesting conditions, which may impact the director’s future equity incentives and align with shareholder interests.
Oneview Healthcare PLC announced the cessation of 11,533,905 restricted share units due to the lapse of conditional rights, as the conditions were not met or became incapable of being satisfied. This development might impact the company’s capital structure and could have implications for its stakeholders, as it reflects on the company’s operational adjustments and strategic decisions.
Oneview Healthcare PLC has released its full-year results for 2024, providing insights into its financial performance. The announcement highlights the company’s adherence to International Financial Reporting Standards and outlines the general economic conditions and competitive landscape affecting its operations. While the release does not offer specific financial figures, it emphasizes the company’s commitment to transparency and regulatory compliance, which could impact investor confidence and market positioning.
Oneview Healthcare PLC issued a correction notice concerning the misreporting of Barbara Nelson’s securities holdings, clarifying that she held 1,077,898 Restricted Share Units (RSUs) instead of Chess Depository Interests (CDIs). This correction, identified through an internal review process, underscores Oneview’s commitment to compliance with ASX Listing Rules, with the company expressing confidence in its improved processes to ensure accurate future disclosures.